New treatments for pulmonary fibrosis?
- 1 November 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 354 (9193) , 1839-1840
- https://doi.org/10.1016/s0140-6736(99)00347-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Pulmonary fibrosis: cytokines in the balanceEuropean Respiratory Journal, 1998
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Survival in Patients With Cryptogenic Fibrosing AlveolitisChest, 1998
- Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.American Journal of Respiratory and Critical Care Medicine, 1997
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989